Across the pharmaceutical industry, supply chain leaders are facing a familiar set of challenges: fragmented data systems, limited visibility, and an overreliance on manual processes. As logistics operations scale to meet global demand, many organisations are discovering that their current infrastructure struggles to keep up - especially when it comes to cold chain compliance, temperature data management, and KPI reporting. Much of the strain comes from the way data is collected and handled. It’s still typical for teams to receive temperature logger outputs in PDF or Excel format, store them in places like SharePoint, and manually clean and reconcile information before it can be analysed. This fragmentation not only slows down operations, it also limits the ability to identify risk patterns or take timely corrective action. Business intelligence (BI) tools are often in place, but they tend to offer retrospective visibility. Most dashboards show what went wrong after the fact - not what

April 16, 2025 Faced with regulatory requirements, geopolitical developments, sustainability pressures and operational complexity, supply chain leaders can no longer afford to operate reactively. To maintain resilience and competitiveness, they must adopt a proactive approach, leveraging data-driven insights and fostering collaboration across the value chain to effectively manage potential disruptions. This was the driving theme behind the CxO Fireside Chat at the LogiPharma 2025 conference. Senior executives from across the pharmaceutical and logistics sectors came together in France in early April to explore what it means to build a truly proactive supply chain, and what it will take to get there. The next five years will be a turning point for pharma supply chains, as the industry will see a dramatic transformation in how manufacturers operate. To learn more about this, we spoke to Adam Ruiz, Growth Business Development Representative at Veratrak, who attended the conference in Fran

Optimising external manufacturing cost-effectiveness while maintaining high-quality standards and regulatory compliance is increasingly complex and challenging. Supply chain professionals face a myriad of challenges that can significantly impact their operations and bottom line. Rising external manufacturing costs are squeezing profit margins, while a lack of supply chain visibility and poor supplier performance hinder efficiency and responsiveness. Meanwhile, ensuring business continuity in the face of disruptions has become a critical imperative. While supply chain disruptions have eased since the COVID-19 pandemic, companies are still grappling with higher costs for materials compared to pre-pandemic levels. Inflation has emerged as a major concern for pharmaceutical companies, with 40% of industry professionals identifying it as the top challenge in 2023¹. This has led to increased costs for raw materials, energy, and labour, putting pressure on profit margins. Regulatory complianc

Relying on a password alone is not enough to keep online accounts safe; many sectors, particularly in life sciences and finance, require stringent security measures. By implementing multi-factor authentication (MFA), companies not only safeguard against data breaches but also ensure they meet regulatory standards, preventing legal and financial repercussions. In this article, we talk to Heléna Kattenhorn, Product Manager at Veratrak, to learn more about the advantages of using MFA as a fundamental component in meeting security requirements and protecting sensitive data. Can you tell us more about MFA, and why it matters? Implementing Multi-factor Authentication (MFA) provides a powerful multi-layered defense. MFA is a security mechanism that requires users to provide two or more verification factors to gain access to a resource such as an application, online account, or VPN. Unlike traditional password-based systems, MFA adds extra layers of security, significantly reducing the risk of

Maintaining data integrity is a critical imperative for pharmaceutical manufacturers to ensure product quality, regulatory compliance, and patient safety. The complexity of global supply networks, coupled with the need for stringent quality control and regulatory compliance, make effective data integration crucial for maintaining operational efficiency, as even minor mistakes in data recording can have far-reaching consequences in pharma manufacturing. In this article, we examine some of the multifaceted data integration challenges pharma manufacturers face across their interconnected supply chain ecosystem, and explore a range of innovative strategies and technological solutions they can use to enhance their data integration processes. Data Integration Challenges Pharmaceutical companies must contend with collaborating with multiple stakeholders, including manufacturers, wholesalers and logistics providers, collecting vast amounts of data from disparate sources to optimise inventory m

December 18, 2024 As we reflect on 2024, here are the top five posts that captured your interest this year. From industry insights to pharma supply chain trends, these posts not only captured your attention but also fostered collective learning and growth across our network. We're looking forward to what 2025 will bring, here's to fantastic year ahead! 1. 5 Key Trends Shaping the CDMO Industry in 2024 2. Shaping the Future at Veratrak 3. Latest Industry Insights From LogiPharma Europe 2024 4. Supply Chain 4.0: Building a Resilient Supply Chain Ecosystem 5. A data-driven approach to reducing your supply chain carbon footprint